Routine BRCA testing for ovarian cancer patients proves feasible in irish study
NCT ID NCT06274541
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether it is practical to routinely check ovarian cancer tumors for BRCA gene mutations in the clinic. Researchers enrolled 200 patients with high-grade serous or endometrioid ovarian, fallopian tube, or primary peritoneal cancer. They used blood and tumor samples to look for BRCA1/2 mutations, aiming to see if this approach works well for doctors and patients, and if it is cost-effective for the healthcare system.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BRCA1/2 genetic testing
What this could lead to
If successful, this could make BRCA testing a standard part of ovarian cancer care, helping doctors choose better treatments and informing family members about their cancer risk.
What could go wrong
This was a small pilot study focused on feasibility, not on patient outcomes. The results may not apply to other healthcare systems or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FALLOPIAN TUBE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bon Secours
Cork, Munster, Ireland
-
Cork University Hospital
Cork, Munster, Ireland
-
Mater Misericordiae University Hospital / Mater Private Hospital
Dublin, Leinster, Ireland
-
St James's Hospital
Dublin, Leinster, Ireland
-
University Hospital Limerick
Limerick, Munster, Ireland